Metabolic disorders represent a growing worldwide health challenge due to their
dramatically increasing prevalence. The gut microbiota is a crucial actor that can interact …

Olive oil (OO) is the main source of added fat in the Mediterranean diet (MD). It is a mix of
bioactive compounds, including monounsaturated fatty acids, phytosterols, simple phenols …

Metabolic diseases such as obesity, type 2 diabetes mellitus, and hyperlipidemia are
associated with the dysfunction of gut microbiota. Traditional Chinese medicines (TCMs) …

ABSTRACT Background Trimethylamine-N-oxide (TMAO) is a gut microbiota–derived
metabolite produced from dietary nutrients. Many studies have discovered that circulating …

Trimethylamine N-oxide (TMAO) is a biologically active gut microbiome-derived dietary
metabolite. Recent studies have shown that high circulating plasma TMAO levels are closely …

Glycolipid metabolism disorder are major threats to human health and life. Genetic,
environmental, psychological, cellular, and molecular factors contribute to their …

Trimethylamine N-oxide (TMAO) is a metabolite produced by the gut microbiota and has
been mainly associated with an increased incidence of cardiovascular diseases (CVDs) in …

Aims Several epidemiological studies have examined the association between
trimethylamine N-Oxide (TMAO) and stroke risk; however, the results are still inconclusive …

Trimethylamine (TMA) and its N-oxide (TMAO) are ubiquitous in prokaryote and eukaryote
organisms as well as in the environment, reflecting their fundamental importance in …

Atherosclerotic cardiovascular disease (ASCVD) is the primary cause of death globally, with
nine million deaths directly attributable to ischemic heart diseases in 2020. Since the last …